Teva, the Israeli pharmaceutical giant, is reaching new heights, breaking the $30 mark. The rise in its share price reflects both the strengthening of its balance sheet and the rising sales of Austedo ...

Regeneron has had its hands full this year contending with regulatory setbacks, Amgen's marketed Eylea biosimilar and Roche's hard-charging ophthalmology rival Vabysmo. Next year, the biosimilar ...

Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement with Regeneron Pharmaceuticals (REGN) concerning the launch of AVT06, Alvotech’s proposed biosimilar to ...

A new mental health-driven biotech has arrived in Syremis Therapeutics. Co-founded by the mind behind Karuna Therapeutics and its novel schizophrenia treatment Cobenfy, the company has officially ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

You may be concerned about the recent declines in AI stocks such as NVDA. However, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing ...

A free daily email with the biggest news stories of the day – and the best features from TheWeek.com Contact me with news and offers from other Future brands Receive email from us on behalf of our ...

Broadly speaking, Marvel doesn't get nearly enough credit for its work in animation. The films in the "Spider-Man: Into the Spider-Verse" series certainly enjoy widespread critical acclaim, so much so ...

“Affordability” was the word of the week. President Donald Trump delivered a prime-time address to the nation about the economy, blaming former President Joe Biden for inflation and high grocery ...

Daily and weekly updates delivered straight to your inbox.